Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder-Reference-Cited by-同舟云学术

Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder

Published:2020-02-18 Issue:1 Volume:189 Page:97-105
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Jain Michael D.¹²^ORCID,Lam Ryan¹,Liu Zhihui¹,Stubbins Ryan J.³⁴,Kahlon Amrit⁴,Kansara Roopesh⁴⁵,Goswami Rashmi⁶,Humar Atul⁷,Prica Anca¹,Sehn Laurie H.⁴,Slack Graham W.⁴,Crump Michael¹,Savage Kerry J.⁴^ORCID,Peters Anthea C.³,Kuruvilla John¹

Affiliation:

1. Princess Margaret Cancer Centre University Health Network University of Toronto Toronto Canada

2. H. Lee Moffitt Cancer Center University of South Florida Morsani College of Medicine Tampa FL USA

3. Cross Cancer Institute University of Alberta Edmonton Canada

4. British Columbia Cancer Centre for Lymphoid Cancer Vancouver Canada

5. Cancer Care Manitoba Winnipeg Canada

6. Sunnybrook Research Institute and Department of Laboratory Medicine and Pathobiology University of Toronto Toronto Canada

7. Toronto General Hospital University Health Network University of Toronto Toronto Canada

Funder

Alberta Innovates Health Solutions

Publisher

Wiley